We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Biomechanical Ratchet Traps Cancer Cells Before They Can Spread

By LabMedica International staff writers
Posted on 29 Jun 2009
Researchers have demonstrated the possibility of using a biomechanical ratchet to sort normal and cancerous cells as a means to trap tumor cells before they spread to other areas of the body. More...


In several important physiologic processes, particularly cancer metastasis, randomly moving cells can acquire a directional motility phenotype and bias their motions in response to environmental cues. Researchers still do not understand why cells migrate in a specific direction.

In the current study, researchers from Northwestern University (Evanston, IL, USA) incorporated molecular cues (cell-adhesive and cell-repellant chemical compounds) into a "microgeometry” substrate that was keyed to the difference in shape between normal epithelial (long and thin with long protrusions on the ends) and cancer (round and broad) cells.

The microscopic ratchets contained channels with "spikes” protruding at 45o angles from the walls, alternating on opposite sides of the channel. This pattern funneled cancer cells in one direction while at the same time directing the normal cells in the opposite direction, as those cells could attach to the spikes and pull themselves through the channel. The cancer cells could be channeled into a closed chamber from which they could not escape.

The feasibility of the system was tested using melanoma, breast cancer, and normal cells, and the results were reported in the June 14, 2009, online edition of the journal Nature Physics.

"We have demonstrated a principle that offers an unconventional way to fight metastasis, a very different approach from other methods, such as chemotherapy,” said senior author Dr. Bartosz Grzybowski, associate professor of chemical and biological engineering at Northwestern University. "These are fundamental studies so the method needs to be optimized, but the idea has promise for a new approach to cancer therapy.”

Related Links:

Northwestern University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.